Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.

scientific article published in August 2013

Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/1751-2980.12064
P698PubMed publication ID23615075

P2093author name stringDong Chen
Xiao Yan Wang
An Bin Hu
Xiang Song Zhang
Zhi Feng Chen
P2860cites workManagement of hepatocellular carcinoma: An updateQ27860530
Clinical applications of positron emission tomography in hepatic tumorsQ39734745
The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma.Q39823357
Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells.Q40813713
Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomographyQ44311389
18F-fluorodeoxyglucose PET/CT predicts tumour progression after transarterial chemoembolization in hepatocellular carcinomaQ46775794
Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.Q46845089
Is contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma?Q53364512
Mid-term outcome of positron emission tomography/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumours--a single-centre experience.Q53445078
The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.Q53521000
What Is the Best Time to Evaluate Treatment Response after Radiofrequency Ablation of Hepatocellular Carcinoma Using Contrast-Enhanced Sonography?Q57763672
P433issue8
P921main subjecthepatectomyQ1514021
recurrent hepatocellular carcinomaQ19000463
Fluorodeoxyglucose Positron Emission Tomography/ Computed TomographyQ130273251
P304page(s)433-438
P577publication date2013-08-01
P1433published inJournal of Digestive DiseasesQ15757872
P1476titleValue of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
P478volume14

Reverse relations

cites work (P2860)
Q5870679418F-FDG PET with or without CT in the diagnosis of extrahepatic metastases or local residual/recurrent hepatocellular carcinoma
Q89701966Clinical usefulness of FDG-PET in patients with hepatocellular carcinoma undergoing surgical resection
Q89282387Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma
Q90136092Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects
Q26830236The Role of PET Imaging Before, During, and After Percutaneous Hepatic and Pulmonary Tumor Ablation

Search more.